Spark Investment Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Spark Investment Management’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-7,400	Closed	-$389K	–	553
2019 Q2	$389K	Sell	7,400 -25,500	-78%	-$1.47M	0.03%	398
2019 Q1	$1.74M	Buy	+32,900	New	+$1.62M	0.08%	273
2018 Q2	–	Sell	-96,200	Closed	-$4.65M	–	757
2018 Q1	$4.65M	Buy	+96,200	New	+$5.37M	0.3%	104
2017 Q4	–	Sell	-23,000	Closed	-$714K	–	844
2017 Q3	$714K	Hold	23,000	–	–	0.04%	436
2017 Q2	$629K	Buy	+23,000	New	+$684K	0.04%	471
2017 Q1	–	Sell	-29,000	Closed	-$419K	–	920
2016 Q4	$419K	Sell	29,000 -35,400	-55%	-$622K	0.03%	520
2016 Q3	$1.48M	Sell	64,400 -89,600	-58%	-$1.71M	0.12%	255
2016 Q2	$2.55M	Buy	154,000 +63,400	+70%	+$1.28M	0.24%	139
2016 Q1	$1.44M	Buy	90,600 +46,500	+105%	+$826K	0.15%	220
2015 Q4	$1.43M	Buy	+44,100	New	+$1.91M	0.18%	173

Other funds holding GBT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Spark Investment Management's GBT Position: Q3 2019 in Review

Spark Investment Management sold out of Global Blood Therapeutics, Inc. (GBT) in Q3 2019, closing a stake of 7,400 shares — an estimated $389K sold.

Spark Investment Management first reported a position in GBT in Q4 2015 and held it in 10 quarters. The position peaked at $4.65M in Q1 2018. 208 funds tracked by Wall St. Rank hold GBT as of Q3 2019.

Spark Investment Management reported no remaining Global Blood Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
Spark Investment Management sold 7,400 Global Blood Therapeutics, Inc. shares in Q3 2019, an estimated $389K.
Spark Investment Management first reported a position in Global Blood Therapeutics, Inc. in Q4 2015 and held it in 10 quarters.
Spark Investment Management's Global Blood Therapeutics, Inc. position peaked at $4.65M in Q1 2018.
208 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q3 2019.

Based on Spark Investment Management's 13F filing for Q3 2019, filed 12 Nov 2019.